Uses Side effects Before taking Directions Dosage What to avoid FAQ What is Rexulti?Rexulti (brexpiprazole) is a prescription antipsychotic medication used in the treatment of major depressive disorder, schizophrenia in adults and children aged 13 years and older, and agitation associated with dementia...
Recommended Dosage for Schizophrenia (Adults and Pediatric Patients 13 to 17 Years) Adults The recommended starting Rexulti dosage for thetreatment of schizophrenia in adults is 1 mg once daily on Days 1 to 4. Titrate to 2 mg once daily on Day 5 through Day 7. On Day 8, the dosage can ...
Rexulti (brexpiprazole) is commonly used to treat people withdepression,schizophrenia, or agitation due to dementia withAlzheimer’s disease. Rexulti may also be used for other conditions as determined by your healthcare provider. How does Rexulti work (mechanism of action)?
Patent use: TREATMENT OF SCHIZOPHRENIA IN ADULTS AND PEDIATRIC PATIENTS AGES 13 YEARS AND OLDER ✓ Drug product April 12, 2026 ✓ Patent use: TREATMENT OF SCHIZOPHRENIA ✓ Drug product Piperazine-substituted benzothiophenes for treatment of mental disordersPatent 9839637*PEDIssued: December 12...
for: • Use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults (1, 14.1) • Treatment of schizophrenia in adults and pediatric patients ages 13 years and older (1, 14.2) --- DOSAGE AND ADMINISTRATION --- Administer REXULTI once dail...
Increased incidence of for REXULTI. cerebrovascular adverse reactions (e.g., stroke, transient ischemic REXULTI® (brexpiprazole) tablets, for oral use attack) (5.3) Initial U.S. Approval: 2015 • Neuroleptic Malignant Syndrome: Manage with immediate discontinuation and close monitoring. (5.4) WA...
Otsuka and Lundbeck Announce FDA Approval of Supplemental New Drug Application for REXULTI ® (brexpiprazole) to Treat Schizophrenia in Pediatric Patients Ages 13-17.
Otsuka and Lundbeck announce the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) of REXULTI® (brexpiprazole) for the treatment of schizophrenia in pediatric patients 13 to 17 years of age. The FDA prev
Rexulti (brexpiprazole) is commonly used to treat people withdepression,schizophrenia, or agitation due to dementia withAlzheimer’s disease. Rexulti may also be used for other conditions as determined by your healthcare provider. How does Rexulti work (mechanism of action)?
Rexulti (brexpiprazole) is commonly used to treat people with depression, schizophrenia, or agitation due to dementia with Alzheimer’s disease. Rexulti may also be used for other conditions as determined by your healthcare provider. How does Rexulti work (mechanism of action)? Rexulti is an anti...